Analysis of organismal and tumor suppressive functions of 14-3sigma
Analysis of organismal and tumor suppressive functions of 14-3sigma
批准号:
61990547
负责人:
Professor Dr. Heiko Hermeking
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2007
资助国家:
德国
项目状态:
已结题
起止时间:
2006-12-31 至 2010-12-31
中文摘要
p53转录因子由肿瘤抑制基因编码,该基因在超过50%的所有癌症中突变。我们鉴定了14-3-3sigma基因作为p53的直接靶点,p53介导了人癌细胞系DNA损伤后G2/M期进展的阻断。在肿瘤中,14-3-3sigma基因经常被CpG甲基化沉默。然而,14-3-3sigma失活与癌症形成及其生物功能的相关性尚不清楚。在这里,我建议在几种组织和细胞类型中使用条件Cre等位基因在成年小鼠中进行14-3-3sigma。这种方法将模拟14-3-3sigma的表观遗传失活,这通常发生在肿瘤形成期间。此外,将分析急性14-3- 3 σ失活对皮肤化学致癌作用的影响以及14-3- 3 σ与肠道中p53介导的DNA损伤反应的相关性。此外,14-3-3sigma的丢失和癌基因激活之间的潜在合作将被研究。敲除另外两个p53靶基因p21和p53 A,在没有额外的应激(如DNA损伤)的情况下也不会导致明显的表型。我们将产生14-3-3sigma、p21和p53 A缺陷的复合基因敲除小鼠,以确定这些缺失对p53介导的肿瘤抑制和DNA损伤反应的联合作用。ER(反复脱毛)小鼠品系在14-3-3sigma基因中携带引起表皮过度增殖的点突变。将比较ER突变和14-3- 3 σ缺失在FVB背景下的功能后果,因为我们的结果表明14-3- 3 σ的ER mut可能不仅仅代表功能缺失突变。总之,这些研究将为理解14-3-3sigma在生理学和病理生理学中的功能做出重要贡献。
英文摘要
The p53 transcription factor is encoded by a tumor suppressor gene which is mutated in more than 50% of all cancers. We identified the 14-3-3sigma gene as a direct target of p53 which mediates inhi-bition of progression through the G2/M phase following DNA damage in a human cancer cell line. In tumors the 14-3-3sigma gene is frequently silenced by CpG-methylation. However, the relevance of 14-3-3sigma inactivation for cancer formation and its organismal function is not known. Here I propose to inactivate 14-3-3sigma in adult mice using conditional Cre alleles in several tissues and cell types. This approach will mimic the epigenetic inactivation of 14-3-3sigma which commonly happens during tumor formation. Furthermore, the effect of acute 14-3-3sigma inactivation on chemical carcinogenesis of the skin and the relevance of 14-3-3sigma for the p53-mediated DNA damage response in the intestinal tract will be analysed. In addition, the potential co-operation between loss of 14-3-3sigma and oncogene activation will be studied. The knock-out of two other p53-target genes, p21 and PUMA, also does not lead to an obvious phenotype without additional stress, as DNA damage. We will generate compound knock-out mice deficient for 14-3-3sigma, p21 and PUMA in order to determine the combined effect of these deletions on the p53-mediated tumor suppression and DNA damage response. The ER (repeated epilation) mouse strain carries a point mutation in the 14-3-3sigma gene which causes epidermal hyper-proliferation. The functional consequences of the ER mutation and 14-3-3sigma deletion on a FVB background will be compared, as our results indicate that the ER mut of 14-3-3sigma may not simply represent a loss of function mutation. In summary, these studies will provide an important contribution to the understanding of 14-3-3sigma function in physiology and patho-physiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Analysis of the p53/HIF-1A/miR-34a pathway in colorectal cancer
-
批准号:398348782
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Professor Dr. Heiko Hermeking
-
依托单位:
Analysis of the c-MYC-associated protein ZNF281
-
批准号:119172693
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Professor Dr. Heiko Hermeking
-
依托单位:
Genetic analysis of AP4 function in stem cells, tumor maintenance and metastasis formation
-
批准号:106373515
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Professor Dr. Heiko Hermeking
-
依托单位:
The Role of RBM47 Inactivation in Colorectal Cancer Progression
-
批准号:463909004
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Heiko Hermeking
-
依托单位:
Function of the p53-induced lncRNA LINC01021 in suppression of colorectal cancer
-
批准号:490846707
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Heiko Hermeking
-
依托单位:
miR-34a-mediated regulations in the micro-environment of colorectal cancer
-
批准号:314976936
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Heiko Hermeking
-
依托单位:
海外基金